WSJ: What are the costs and benefits of early cancer screening?

Early cancer screening is causing a rise of unnecessarily aggresive treatments for non-serious abnormalities. But reducing early screening isn't much of an option either, with over half a million Americans dying from cancer annually, many from fast-developing cancers that spread quickly between screenings. At the National Cancer Institute, doctors are compiling new screening guidelines. They recommend swift development of new screening programs to find the deadliest cancers, registries to track lower-risk cancers and the removal of the term 'cancer' from slow-growing, precancerous tumors that are unlikely to progress and shouldn't be treated aggressively. News

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.